Status: Recruiting
Atacicept in Multiple Glomerular Diseases
A study to find how well atacicept works and how safe it is in participants with autoimmune kidney disease.
Participants needed: 250
Trial details
Phase: Phase 2Age: 2+Biological sex: AllType: InterventionalSponsor: Vera Therapeutics, Inc.Updated: Jun 26, 2026Locations: 1
Eligibility criteria
Weight of at least 40 kg [+21]
Evidence of rapidly progressive glomerulonephritis (loss of ≥50% of eGFR) within... [+6]